A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens.
暂无分享,去创建一个
Hong Wu | Shuang Hou | Michael E Phelps | R Michael van Dam | Paul S Mischel | Nangang Zhang | Hsian-Rong Tseng | Hao Wang | Ki-Bum Lee | Dan R Laks | Harley I Kornblum | Jing Sun | William H Yong | Jason DeJesus | T. Graeber | H. Tseng | L. Liau | P. Mischel | M. Phelps | Hao Wang | H. Kornblum | Hong Wu | J. Jiao | R. M. van Dam | N. Graham | Nangang Zhang | J. Lazareff | Z. T. Yu | K. Kamei | Ki-Bum Lee | J. Mottahedeh | David Nathanson | E. Panosyan | Hao Wang | W. Yong | Jing Sun | Michael Masterman-Smith | D. Laks | M. Ohashi | Jason Dejesus | Yi-Tsung Lu | S. Hou | Keyu Li | Max Liu | Shutao Wang | B. Angénieux | E. Samuels | Jun K Park | Dirk Williams | Vera Konkankit | Linda M Liau | Jorge A Lazareff | David Nathanson | Ken-ichiro Kamei | Thomas G Graeber | Shutao Wang | Yi-Tsung Lu | Jing Jiao | Zeta T F Yu | Michael D Masterman-Smith | Nicholas A Graham | Jack Mottahedeh | Minori Ohashi | Keyu Li | Max Liu | Brigitte Angenieux | Eduard Panosyan | Eric R Samuels | Jun Park | Dirk Williams | Vera Konkankit | D. Nathanson | Jason DeJesus | M. Masterman‐Smith
[1] Bert Vogelstein,et al. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies , 2006, Nature Biotechnology.
[2] C. James,et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. , 2001, Journal of the National Cancer Institute.
[3] Paul S Mischel,et al. Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo. , 2003, Cancer research.
[4] Yasodha Natkunam,et al. Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens , 2009, Nature Medicine.
[5] Peter O. Krutzik,et al. Intracellular phospho‐protein staining techniques for flow cytometry: Monitoring single cell signaling events , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[6] Junbai Wang,et al. Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study , 2002, BMC Bioinformatics.
[7] S. Quake,et al. Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis , 2008, Nature Biotechnology.
[8] Teuvo Kohonen,et al. The self-organizing map , 1990 .
[9] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[10] Sophia Adamia,et al. Microfluidic chips for detecting the t(4;14) translocation and monitoring disease during treatment using reverse transcriptase-polymerase chain reaction analysis of IgH-MMSET hybrid transcripts. , 2007, Journal of Molecular Diagnostics.
[11] Jonathan M Irish,et al. Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells , 2004, Cell.
[12] C. García-echeverría,et al. PI3K and mTOR inhibitors: a new generation of targeted anticancer agents. , 2009, Current opinion in cell biology.
[13] S. Horvath,et al. Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma , 2009, Stem cells.
[14] J. Mesirov,et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] D. Rimm,et al. Immunohistochemistry and quantitative analysis of protein expression. , 2009, Archives of pathology & laboratory medicine.
[17] Daniel H. Geschwind,et al. Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] K. Hunter,et al. Mapping normal and cancer cell signalling networks: towards single-cell proteomics , 2006 .
[19] D. Louis,et al. Influence of unrecognized molecular heterogeneity on randomized clinical trials. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] E. Domany,et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] R. Yu,et al. Single-cell quantification of molecules and rates using open-source microscope-based cytometry , 2007, Nature Methods.
[22] Nader Sanai,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma. , 2010, World neurosurgery.
[23] Garry P. Nolan,et al. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry , 2002, Nature Biotechnology.
[24] Hong Wu,et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. , 2003, Cancer cell.
[25] Hsian-Rong Tseng,et al. An integrated microfluidic culture device for quantitative analysis of human embryonic stem cells. , 2009, Lab on a chip.
[26] Zhifei Wang,et al. Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis. , 2011, The Journal of surgical research.
[27] Raymond R Tubbs,et al. Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines. , 2005, Human pathology.
[28] Garry P Nolan,et al. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling , 2006, Nature Methods.
[29] M. Berger,et al. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] Jesse V Jokerst,et al. Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. , 2009, Biosensors & bioelectronics.
[31] P. Kleihues,et al. Predominant Expression of Mutant EGFR (EGFRvIII) is Rare in Primary Glioblastomas , 2004, Brain pathology.
[32] C. Brennan,et al. Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations , 2009, PloS one.
[33] K. Jensen,et al. Cells on chips , 2006, Nature.
[34] S. Nelson,et al. DNA-microarray analysis of brain cancer: molecular classification for therapy , 2004, Nature Reviews Neuroscience.
[35] L. Hood,et al. Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood , 2008, Nature Biotechnology.
[36] James R Heath,et al. Nanotechnology and cancer. , 2008, Annual review of medicine.
[37] Koji Yoshimoto,et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. , 2005, The New England journal of medicine.
[38] Bo Huang,et al. Counting Low-Copy Number Proteins in a Single Cell , 2007, Science.
[39] Forest M White,et al. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma , 2007, Proceedings of the National Academy of Sciences.
[40] Elisa Lee,et al. Statistical Methods for Survival Data Analysis: Lee/Survival Data Analysis , 2003 .
[41] S. Horvath,et al. Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma , 2008, PLoS medicine.
[42] Jonathan M Irish,et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. , 2008, Cancer cell.
[43] T. Cloughesy,et al. PTEN-Mediated Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors , 2007, Clinical Cancer Research.
[44] Lutgarde M. C. Buydens,et al. Self- and Super-organizing Maps in R: The kohonen Package , 2007 .
[45] C. James,et al. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[46] Andre Levchenko,et al. High Content Cell Screening in a Microfluidic Device*S , 2009, Molecular & Cellular Proteomics.
[47] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[48] T. Cloughesy,et al. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. , 2006, Cancer research.